Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T.

Aryal MP, Nagaraja TN, Keenan KA, Bagher-Ebadian H, Panda S, Brown SL, Cabral G, Fenstermacher JD, Ewing JR.

Magn Reson Med. 2014 Jun;71(6):2206-14. doi: 10.1002/mrm.24873. Epub 2013 Jul 22.

2.

Brain edema and blood-brain barrier opening after photothrombotic ischemia in rat.

Kuroiwa T, Xi G, Hua Y, Nagaraja TN, Fenstermacher JD, Keep RF.

Acta Neurochir Suppl. 2013;118:11-5. doi: 10.1007/978-3-7091-1434-6_2.

PMID:
23564097
3.
4.

The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model.

Paudyal R, Ewing JR, Nagaraja TN, Bagher-Ebadian H, Knight RA, Panda S, Lu M, Ledbetter K, Fenstermacher JD.

Magn Reson Med. 2011 Nov;66(5):1422-31. doi: 10.1002/mrm.22914. Epub 2011 May 31.

5.

Modeling of Look-Locker estimates of the magnetic resonance imaging estimate of longitudinal relaxation rate in tissue after contrast administration.

Paudyal R, Bagher-Ebadian H, Nagaraja TN, Fenstermacher JD, Ewing JR.

Magn Reson Med. 2011 Nov;66(5):1432-44. doi: 10.1002/mrm.22852. Epub 2011 May 31.

6.

Multiparametric magnetic resonance imaging and repeated measurements of blood-brain barrier permeability to contrast agents.

Nagaraja TN, Knight RA, Ewing JR, Karki K, Nagesh V, Fenstermacher JD.

Methods Mol Biol. 2011;686:193-212. doi: 10.1007/978-1-60761-938-3_8.

7.

Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice.

Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF.

J Cereb Blood Flow Metab. 2011 Jan;31(1):250-61. doi: 10.1038/jcbfm.2010.84. Epub 2010 Jun 23.

9.

MRI estimation of gadolinium and albumin effects on water proton.

Bagher-Ebadian H, Paudyal R, Nagaraja TN, Croxen RL, Fenstermacher JD, Ewing JR.

Neuroimage. 2011 Jan;54 Suppl 1:S176-9. doi: 10.1016/j.neuroimage.2010.05.032. Epub 2010 May 20.

10.

Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA.

Knight RA, Karki K, Ewing JR, Divine GW, Fenstermacher JD, Patlak CS, Nagaraja TN.

J Cereb Blood Flow Metab. 2009 May;29(5):1048-58. doi: 10.1038/jcbfm.2009.20. Epub 2009 Mar 25.

11.

Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen.

Kuroiwa T, Xi G, Hua Y, Nagaraja TN, Fenstermacher JD, Keep RF.

Stroke. 2009 Jan;40(1):248-53. doi: 10.1161/STROKEAHA.108.527853. Epub 2008 Nov 26.

12.

MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration.

Ewing JR, Brown SL, Nagaraja TN, Bagher-Ebadian H, Paudyal R, Panda S, Knight RA, Ding G, Jiang Q, Lu M, Fenstermacher JD.

J Magn Reson Imaging. 2008 Jun;27(6):1430-8. doi: 10.1002/jmri.21356.

13.

Reporter gene imaging using radiographic contrast from nonradioactive iodide sequestered by the sodium-iodide symporter.

Brown SL, Freytag SO, Barton KN, Flynn MJ, Peck DJ, Dragovic AF, Jin R, Yeni YN, Fyhrie DP, Les CM, Zhu G, Kolozsvary A, Pitchford WC, Nathanson SD, Fenstermacher JD, Kim JH.

Contrast Media Mol Imaging. 2007 Sep-Oct;2(5):240-7.

PMID:
18058866
14.
15.

MRI estimation of contrast agent concentration in tissue using a neural network approach.

Bagher-Ebadian H, Nagaraja TN, Paudyal R, Whitton P, Panda S, Fenstermacher JD, Ewing JR.

Magn Reson Med. 2007 Aug;58(2):290-7.

16.

Relative distribution of plasma flow markers and red blood cells across BBB openings in acute cerebral ischemia.

Nagaraja TN, Keenan KA, Brown SL, Fenstermacher JD, Knight RA.

Neurol Res. 2007 Jan;29(1):78-80.

PMID:
17427280
17.

Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections.

Nagaraja TN, Nagesh V, Ewing JR, Whitton PA, Fenstermacher JD, Knight RA.

Magn Reson Imaging. 2007 Apr;25(3):311-8. Epub 2006 Nov 7.

18.

Acute neurovascular unit protection by simvastatin in transient cerebral ischemia.

Nagaraja TN, Knight RA, Croxen RL, Konda KP, Fenstermacher JD.

Neurol Res. 2006 Dec;28(8):826-30.

PMID:
17288739
19.

Role of angiotensin II in retinal leukostasis in the diabetic rat.

Chen P, Scicli GM, Guo M, Fenstermacher JD, Dahl D, Edwards PA, Scicli AG.

Exp Eye Res. 2006 Nov;83(5):1041-51. Epub 2006 Jul 5. Erratum in: Exp Eye Res. 2007 Nov;85(5):738.

PMID:
16822509
20.

Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent.

Nagaraja TN, Croxen RL, Panda S, Knight RA, Keenan KA, Brown SL, Fenstermacher JD, Ewing JR.

J Neurosci Methods. 2006 Oct 30;157(2):238-45. Epub 2006 Jun 12.

PMID:
16769125
21.

9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.

Guo M, Roman RJ, Fenstermacher JD, Brown SL, Falck JR, Arbab AS, Edwards PA, Scicli AG.

J Pharmacol Exp Ther. 2006 Apr;317(1):97-108. Epub 2005 Dec 13.

PMID:
16352703
22.

Arterial spin labeling: validity testing and comparison studies.

Ewing JR, Cao Y, Knight RA, Fenstermacher JD.

J Magn Reson Imaging. 2005 Dec;22(6):737-40.

PMID:
16261575
23.

Acute blood-brain barrier opening in experimentally induced focal cerebral ischemia is preferentially identified by quantitative magnetization transfer imaging.

Knight RA, Nagesh V, Nagaraja TN, Ewing JR, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD.

Magn Reson Med. 2005 Oct;54(4):822-32.

24.

Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia.

Knight RA, Nagaraja TN, Ewing JR, Nagesh V, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD.

Magn Reson Med. 2005 Oct;54(4):813-21.

25.

Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.

Ewing JR, Brown SL, Lu M, Panda S, Ding G, Knight RA, Cao Y, Jiang Q, Nagaraja TN, Churchman JL, Fenstermacher JD.

J Cereb Blood Flow Metab. 2006 Mar;26(3):310-20.

PMID:
16079791
26.

In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain.

Nagaraja TN, Patel P, Gorski M, Gorevic PD, Patlak CS, Fenstermacher JD.

Cerebrospinal Fluid Res. 2005 Jul 26;2:5.

27.
28.

A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors.

Barton KN, Xia X, Yan H, Stricker H, Heisey G, Yin FF, Nagaraja TN, Zhu G, Kolozsvary A, Fenstermacher JD, Lu M, Kim JH, Freytag SO, Brown SL.

Mol Ther. 2004 Apr;9(4):625-31.

29.

Estimating blood-brain barrier opening in a rat model of hemorrhagic transformation with Patlak plots of Gd-DTPA contrast-enhanced MRI.

Fenstermacher JD, Knight RA, Ewing JR, Nagaraja T, Nagesh V, Yee JS, Arniego PA.

Acta Neurochir Suppl. 2003;86:35-7.

PMID:
14753399
30.

Sickle red blood cells accumulate in tumor.

Brown SL, Ewing JR, Nagaraja TN, Swerdlow PS, Cao Y, Fenstermacher JD, Kim JH.

Magn Reson Med. 2003 Dec;50(6):1209-14.

31.

GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo.

Barton KN, Tyson D, Stricker H, Lew YS, Heisey G, Koul S, de la Zerda A, Yin FF, Yan H, Nagaraja TN, Randall KA, Jin GK, Fenstermacher JD, Jhiang S, Ho Kim J, Freytag SO, Brown SL.

Mol Ther. 2003 Sep;8(3):508-18.

32.

Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening.

Ewing JR, Knight RA, Nagaraja TN, Yee JS, Nagesh V, Whitton PA, Li L, Fenstermacher JD.

Magn Reson Med. 2003 Aug;50(2):283-92.

33.

Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model.

Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA.

Neurol Res. 2003 Jun;25(4):377-82.

PMID:
12870264
34.

Direct comparison of local cerebral blood flow rates measured by MRI arterial spin-tagging and quantitative autoradiography in a rat model of experimental cerebral ischemia.

Ewing JR, Wei L, Knight RA, Pawa S, Nagaraja TN, Brusca T, Divine GW, Fenstermacher JD.

J Cereb Blood Flow Metab. 2003 Feb;23(2):198-209.

PMID:
12571451
35.

Acute postischemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats.

Li F, Liu KF, Silva MD, Meng X, Gerriets T, Helmer KG, Fenstermacher JD, Sotak CH, Fisher M.

AJNR Am J Neuroradiol. 2002 Feb;23(2):180-8.

36.

Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia.

Liu KF, Li F, Tatlisumak T, Garcia JH, Sotak CH, Fisher M, Fenstermacher JD.

Stroke. 2001 Aug;32(8):1897-905.

PMID:
11486123
37.

Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology.

Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, Fisher M, Hsu CY, Lin W.

Stroke. 2000 Apr;31(4):946-54.

PMID:
10754004
38.

Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains.

Majid A, He YY, Gidday JM, Kaplan SS, Gonzales ER, Park TS, Fenstermacher JD, Wei L, Choi DW, Hsu CY.

Stroke. 2000 Nov;31(11):2707-14.

PMID:
11062298
39.

Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats.

Li F, Silva MD, Liu KF, Helmer KG, Omae T, Fenstermacher JD, Sotak CH, Fisher M.

Ann Neurol. 2000 Aug;48(2):236-44.

PMID:
10939575
40.
41.

Effects of barbiturates on facilitative glucose transporters are pharmacologically specific and isoform selective.

Haspel HC, Stephenson KN, Davies-Hill T, El-Barbary A, Lobo JF, Croxen RL, Mougrabi W, Koehler-Stec EM, Fenstermacher JD, Simpson IA.

J Membr Biol. 1999 May 1;169(1):45-53.

PMID:
10227851
42.

Local cerebral blood flow during the first hour following acute ligation of multiple arterioles in rat whisker barrel cortex.

Wei L, Craven K, Erinjeri J, Liang GE, Bereczki D, Rovainen CM, Woolsey TA, Fenstermacher JD.

Neurobiol Dis. 1998 Sep;5(3):142-50.

PMID:
9848087
43.

The rapid flow of cerebrospinal fluid from ventricles to cisterns via subarachnoid velae in the normal rat.

Fenstermacher JD, Ghersi-Egea JF, Finnegan W, Chen JL.

Acta Neurochir Suppl. 1997;70:285-7.

PMID:
9416348
45.

Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat.

Ghersi-Egea JF, Finnegan W, Chen JL, Fenstermacher JD.

Neuroscience. 1996 Dec;75(4):1271-88.

PMID:
8938759
46.

Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries.

Ghersi-Egea JF, Gorevic PD, Ghiso J, Frangione B, Patlak CS, Fenstermacher JD.

J Neurochem. 1996 Aug;67(2):880-3.

PMID:
8764620
47.

Blood-brain interfaces: relevance to cerebral drug metabolism.

Ghersi-Egea JF, Leininger-Muller B, Cecchelli R, Fenstermacher JD.

Toxicol Lett. 1995 Dec;82-83:645-53. Review.

PMID:
8597122
48.

Nicotine raises the influx of permeable solutes across the rat blood-brain barrier with little or no capillary recruitment.

Chen JL, Wei L, Bereczki D, Hans FJ, Otsuka T, Acuff V, Ghersi-Egea JF, Patlak C, Fenstermacher JD.

J Cereb Blood Flow Metab. 1995 Jul;15(4):687-98.

PMID:
7790419
49.

Barbiturates inhibit hexose transport in cultured mammalian cells and human erythrocytes and interact directly with purified GLUT-1.

Honkanen RA, McBath H, Kushmerick C, Callender GE, Scarlata SF, Fenstermacher JD, Haspel HC.

Biochemistry. 1995 Jan 17;34(2):535-44.

PMID:
7819247
50.

Cross-flow membrane plasmapheresis technique for continuous ex vivo plasma sampling.

Bungay PM, Fenstermacher JD, Krindel P, Dedrick RL, Patlak CS.

J Pharmacol Toxicol Methods. 1994 Nov;32(3):177-85.

PMID:
7858312

Supplemental Content

Loading ...
Support Center